Pharmacokinetics and metabolite identification study of flavonoid dimer FD18 : a potent p-glycoprotein modulator in reversing cancer drug resistance

J.W.Y. Kan; C.S.W. Yan; I.L.K. Wong; Kin Fai Chan; T.H. Chan; Ming Cheung Chow

Pharmacokinetics and metabolite identification study of flavonoid dimer FD18 : a potent p-glycoprotein modulator in reversing cancer drug resistance

J.W.Y. Kan
, C.S.W. Yan
, I.L.K. Wong
, Kin Fai Chan
, T.H. Chan
, Ming Cheung Chow

Research output: Journal article publication › Journal article › Academic research › peer-review

Original language	English
Article number	205
Pages (from-to)	s71
Number of pages	1
Journal	European Journal of Cancer
Volume	69
Publication status	Published - 2016
Event	EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Duration: 1 Jan 2016 → …

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{7b9d01ad24b04819876d2a52cf89b066,

title = "Pharmacokinetics and metabolite identification study of flavonoid dimer FD18 : a potent p-glycoprotein modulator in reversing cancer drug resistance",

author = "J.W.Y. Kan and C.S.W. Yan and I.L.K. Wong and Chan, \{Kin Fai\} and T.H. Chan and Chow, \{Ming Cheung\}",

year = "2016",

language = "English",

volume = "69",

pages = "s71",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

note = "EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics ; Conference date: 01-01-2016",

}

TY - JOUR

T1 - Pharmacokinetics and metabolite identification study of flavonoid dimer FD18 : a potent p-glycoprotein modulator in reversing cancer drug resistance

AU - Kan, J.W.Y.

AU - Yan, C.S.W.

AU - Wong, I.L.K.

AU - Chan, Kin Fai

AU - Chan, T.H.

AU - Chow, Ming Cheung

PY - 2016

Y1 - 2016

M3 - Journal article

SN - 0959-8049

VL - 69

SP - s71

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 205

T2 - EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Y2 - 1 January 2016

ER -